Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Aaron, Shawn D ^a   Vandemheen, Katherine L ^a   Ramsay, Timothy ^a   Zhang, Chun ^b   Avnur, Zafrira ^b   Nikolcheva, Tania ^b   Quinn, Anthony ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLLAGENASE 3; CORTICOSTEROID DERIVATIVE; EOTAXIN 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PROTEIN; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN; AUTACOID;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; IMMUNOASSAY; LUNG FUNCTION; MALE; PROSPECTIVE STUDY; RELIABILITY; SPUTUM LEVEL; AGED; BLOOD; CASE CONTROL STUDY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROTEIN MICROARRAY; REPRODUCIBILITY; SPUTUM; STATISTICAL MODEL; TIME;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPUTUM; TIME FACTORS;

EID: 77954653793     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-41     Document Type: Article

References (20)

1. Di Stefano A, Turato G, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. American Journal of Respiratory & Critical Care Medicine 1996, 153(2):629-632.
2. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. American Review of Respiratory Disease 1989, 140(6):1527-1537.
3. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS. C-reative protein in patients with COPD, control smokers and non-smokers. Thorax 2006, 61:23-28. 10.1136/thx.2005.042200, 2080714, 16143583.
4. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis faxtor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. American Journal of Respiratory and Critical Care Medicine 1996, 153:530-534.
5. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR. Advanced multiplexed analysis with the FlowMetrix system. Clinical Chemistry 1997, 43(9):1749-1756.
6. Franciosi L, Page CP, Celli B, Cazzola M, Walker M, Danhof M. Markers of disease severity in chronic obstuctive pulmonary disease. Pulmonary Pharmacology & Therapeutics 2006, 19:189-199.
7. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758. 10.1378/chest.85.6.751, 6723384.
8. Ferris BG. Epidemiology Standardization Project. Am Rev Respir Dis 1978, 118(6 pt 2):1-88.
9. Kips JC, Inman MD, Jayaram L, Bel EH, Parameswaran K, Pizzichini MM. The use of induced sputum in clinical trials. European Respiratory Journal - Supplement. 2002, 37:47s-50s.
10. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. Journal of Immunological Methods 1999, 227(1-2):41-52. 10.1016/S0022-1759(99)00069-1, 10485253.
11. Moody M, Van Arsdell S, Murphy K, Orencole S, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques 2001, 31:186-190.
12. Harris EK, Yasak T. On the calculation of a 'reference change' for comparing two consecutive measurements. Clin Chem 1983, 29:25-30.
13. Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley R. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008, 63:493-503. 10.1136/thx.2007.086751, 18057097.
14. Man S, Connett JE, Anthonisen NR, Wise RA, Tashkin D, Sin D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853. 10.1136/thx.2006.059808, 2104755, 16738034.
15. Perera W, Hurst JR, Wilkinson TMA, Sapsford R, Mullerova H, Donaldson GC. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007, 29:527-534. 10.1183/09031936.00092506, 17107990.
16. Kanazawa H, Asai K, Nomura S. Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD. Respiratory Research 2007, 8(22). 1828053, 17343763.
17. Siafakas N, Antoniou K, Tzortzaki E. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J of COPD 2007, 2(4):453-462.
18. Andelid K, Bake B, Rak S, Linden A, Rosengren A, Ekberg-Jansson A. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med 2007, 101:888-895. 10.1016/j.rmed.2006.09.023, 17098408.
19. Barczyk A, Sozanska E, Trzaska M, ala W, Pierzchala W. Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest 2004, 126:389-393. 10.1378/chest.126.2.389, 15302722.
20. Gompertz S, Hill AT, Bayley DL, Stockley RA. Effect of expectoration on inflammation in induced sputum in alpha-1 antitrypsin deficiency. Resp Medicine 2006, 100:1094-1099.